Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 44
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.

  • Martín Ruiz Valdepeñas, María Asunción
  • Fiuza Luces, C.
  • Rincón Castanedo, C.
  • Fernández Moreno, D.
  • González Gálvez, Beatriz
  • Martínez Martínez, Ernesto
  • Martín Acosta, P.
  • Coronado, M. J.
  • Franco Luzón, L.
  • González Murillo, A.
  • Ramírez, M.
  • Provencio, M.
  • Lucia, A.
Background: Lung cancer has the highest incidence and mortality rate in the world. One of the most promising new cancer therapies in recent years is immunotherapy, which is based on the blockade of immune checkpoints such as programmed cell death protein 1 (PD-1). Exercise training is beneficial to maintain and improve the quality of life of cancer patients, and it might also modulate the anti-tumoral efficiency of some chemotherapeutic agents. However, the potential of exercise combined with immunotherapy as a cancer therapy remains to be elucidated. Here, we examined the effects of exercise on tumor growth and its possible adjuvant effects when combined with anti-PD-1 immunotherapy (nivolumab) in a patient derived xenograft (PDX) model of non-small-cell lung carcinoma (NSCLC). Methods: We generated a PDX model using NOD-SCID gamma mice with subcutaneous grafts from tumor tissue of a patient with NSCLC. Animals were randomly assigned to one of four groups: non-exercise + isotype control (n=5), exercise + isotype control (n=5), non-exercise + nivolumab (n=6) or exercise + nivolumab (n=6). The animals undertook an 8- week moderate-intensity training regimen (treadmill aerobic exercise and strength training). Immunotherapy (nivolumab) or an isotype control was administered 2 days/week, for 6 weeks. Several tumor growth and microenvironment parameters were measured after the intervention. Results: Improvements in aerobic capacity and muscle strength (p=0.027 and p=0.005) were noted in exercised animals. Exercise alone reduced the tumor growth rate with respect to non-exercised mice (p=0.050). The double intervention (exercise + nivolumab) increased tumor necrosis and reduced apoptosis with respect to controls (p=0.026; p=0.030). All interventions achieved a reduction in proliferation compared with the control group (p=0.015, p=0.011, and p=0.011). Exercise alone increased myeloid tumor infiltrates (mostly neutrophils) with respect to the nivolumab only group (p=0.018). Finally, Vegf-a expression was higher in the nivolumab groups (in combination or not with exercise) than in exercise + isotype control group (p=0.045 and p=0.047, respectively). No other significant effects were found. Conclusions: Our results would suggest that aerobic and strength training should be studied as an adjuvant to cancer immunotherapy treatment.
Docta Complutense
Publication Artículo científico (JournalArticle)

Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice

  • Gómez Hernández, María De La Almudena
  • Raposo López-Pastor, Andrea
  • Rubio-Longas, Carlota
  • Majewski, Patrik
  • Beneit, Nuria
  • Viana-Huete, Vanesa
  • García-Gómez, Gema
  • Fernandez, Silvia
  • Hribal, Marta Letizia
  • Sesti, Giorgio
  • Escribano Illanes, Óscar
  • Benito De Las Heras, Manuel R.
Objective: An increase in mass and/or brown adipose tissue (BAT) functionality leads to an increase in energy expenditure, which may be beneficial for the prevention and treatment of obesity. Moreover, distinct class I PI3K isoforms can participate in metabolic control as well as in systemic dysfunctions associated with obesity. In this regard, we analyzed in vivo whether the lack of p85a in BAT (BATp85aKO) could modulate the activity and insulin signaling of this tissue, thereby improving diet-induced obesity and its associated metabolic complications. Methods: We generated BATp85aKO mice using Cre-LoxP technology, specifically deleting p85a in a conditional manner. To characterize this new mouse model, we used mice of 6 and 12 months of age. In addition, BATp85aKO mice were submitted to a high-fat diet (HFD) to challenge BAT functionality. Results: Our results suggest that the loss of p85a in BAT improves its thermogenic functionality, high-fat dieteinduced adiposity and body weight, insulin resistance, and liver steatosis. The potential mechanisms involved in the improvement of obesity include (1) increased insulin signaling and lower activation of JNK in BAT, (2) enhanced insulin receptor isoform B (IRB) expression and association with IRS-1 in BAT, (3) lower production of proinflammatory cytokines by the adipose organ, (4) increased iWAT browning, and (5) improved liver steatosis. Conclusions: Our results provide new mechanisms involved in the resistance to obesity development, supporting the hypothesis that the gain of BAT activity induced by the lack of p85a has a direct impact on the prevention of diet-induced obesity and its associated metabolic complications
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

  • García-Escobar, Eva|||0000-0002-0134-3473
  • Valdés, Sergio|||0000-0001-8623-4331
  • Soriguer, Federico|||0000-0002-1992-5666
  • Vendrell, Joan|||0000-0002-6994-6115
  • Urrutia Etxebarria, Inés M.|||0000-0001-5386-8776
  • Maldonado-Araque, Cristina
  • Ortega, Emilio|||0000-0002-2217-8905
  • Ocón, Pilar|||0000-0001-9257-2687
  • Montanya, Eduard|||0000-0003-2518-9076
  • Menéndez Torre, Edelmiro|||0000-0002-9548-7821
  • Lago-Sampedro, Ana Maria
  • González-Frutos, Teba
  • Gomis, Ramon|||0000-0002-7285-1328
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • García-Serrano, Sara
  • Galán-García, José Luis|||0000-0002-8773-6998
  • Castell, Conxa|||0000-0003-2558-1959
  • Bordiú, Elena
  • Badía-Guillén, Rocío
  • Aguilera-Venegas, Gabriel|||0000-0002-5813-6184
  • Girbés, Juan|||0000-0002-1665-4549
  • Gaztambide, Sonia|||0000-0003-3569-2265
  • Delgado, Elias|||0000-0001-6114-9712
  • Chaves, Felilpe Javier|||0000-0001-8009-3689
  • Castaño, Luis|||0000-0003-0437-9401
  • Calle-Pascual, Alfonso
  • Rojo-Martínez, G.|||0000-0003-2179-2134
  • Franch-Nadal, Josep|||0000-0002-5175-1555
Our aim was to evaluate whether fatty liver index (FLI) is associated with the risk of type 2 diabetes (T2DM) development within the Spanish adult population and according to their prediabetes status; additionally, to examine its incremental predictive value regarding traditional risk factors. A total of 2260 subjects (Prediabetes: 641 subjects, normoglycemia: 1619 subjects) from the Di@bet.es cohort study were studied. Socio-demographic, anthropometric, clinical data and survey on habits were recorded. An oral glucose tolerance test was performed and fasting determinations of glucose, lipids and insulin were made. FLI was calculated and classified into three categories: Low (< 30), intermediate (30-60) and high (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Altered resting-state functional connectivity in individuals at risk for Alzheimer's disease, a longitudinal study

  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Maturana-Quijada, Pablo
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Juaneda-Seguí, Asier
  • Guinea-Izquierdo, Andrés
  • Gascon Bayarri, Jordi|||0000-0002-9422-937X
  • Reñé-Ramírez, Ramón
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Resting-state functional connectivity magnetic resonance imaging (rs-fMRI) is a sensitive tool for detecting early brain changes associated with Alzheimer's disease, even in its preclinical stages. Amnestic mild cognitive impairment (aMCI) and late-life depression (LLD) are two prevalent conditions in older adults that significantly elevate the risk of cognitive decline and dementia. This study aimed to elucidate the underlying neurobiological substrates by longitudinally identifying and comparing distinct connectivity patterns in aMCI subjects and LLD patients, and by examining the associations between these patterns and clinical measures of cognitive and mood impairments. The study included three groups: 26 healthy controls (HCs), 15 individuals with aMCI, and 21 patients with LLD. All participants underwent rs-fMRI and neuropsychological assessments at baseline and at a 2-year follow-up. Functional connectivity was analyzed using a group Independent Component Analysis (ICA) model to investigate both group differences and longitudinal changes over time. At baseline, individuals with aMCI exhibited reduced functional connectivity in the precuneus, whereas LLD patients showed decreased connectivity in frontal, insular, and postcentral regions alongside increased connectivity in posterior parietal and cuneal cortices. Correlation analyses revealed that lower baseline insular connectivity predicted higher depressive symptoms at follow-up in aMCI subjects. In LLD, reduced baseline precuneus connectivity was associated with better two-year outcomes in global cognition and long-term memory. This study provides evidence of distinct alterations in resting-state functional connectivity in individuals with aMCI and LLD, underscoring region-specific vulnerabilities that may contribute to cognitive decline and depressive symptomatology in older adults.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Gradogna, Antonella
  • Laparra-Cuervo, Lara
  • Solsona, Carles
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Lakadamyali, Melike
  • Estévez, Raúl|||0000-0003-1579-650X
Volume-regulated anion channels (VRACs) play an important role in controlling cell volume by opening upon cell swelling. Recent work has shown that heteromers of LRRC8A with other LRRC8 members (B, C, D, and E) form the VRAC. Here, we used Xenopus oocytes as a simple system to study LRRC8 proteins. We discovered that adding fluorescent proteins to the C-terminus resulted in constitutive anion channel activity. Using these constructs, we reproduced previous findings indicating that LRRC8 heteromers mediate anion and osmolyte flux with subunit-dependent kinetics and selectivity. Additionally, we found that LRRC8 heteromers mediate glutamate and ATP flux and that the inhibitor carbenoxolone acts from the extracellular side, binding to probably more than one site. Our results also suggest that the stoichiometry of LRRC8 heteromers is variable, with a number of subunits ≥6, and that the heteromer composition depends on the relative expression of different subunits. The system described here enables easy structure-function analysis of LRRC8 proteins.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Evidence of the Red-Queen hypothesis from accelerated rates of evolution of genes involved in biotic interactions in Pneumocystis

  • Delaye, Luis
  • Ruiz Ruiz, Susana
  • Calderon, Enrique
  • Conesa, A.
  • Moya, Andrés
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Pneumocystis species are ascomycete fungi adapted to live inside the lungs of mammals. These ascomycetes show extensive stenoxenism, meaning that each species of Pneumocystis infects a single species of host. Here, we study the effect exerted by natural selection on gene evolution in the genomes of three Pneumocystis species. We show that genes involved in host interaction evolve under positive selection. In the first place, we found strong evidence of episodic diversifying selection in Major surface glycoproteins (Msg). These proteins are located on the surface of Pneumocystis and are used for host attachment and probably for immune system evasion. Consistent with their function as antigens, most sites under diversifying selection in Msg code for residues with large relative surface accessibility areas. We also found evidence of positive selection in part of the cell machinery used to export Msg to the cell surface. Specifically, we found that genes participating in glycosylphosphatidylinositol (GPI) biosynthesis show an increased rate of nonsynonymous substitutions (dN) versus synonymous substitutions (dS). GPI is a molecule synthesized in the endoplasmic reticulum that is used to anchor proteins to membranes. We interpret the aforementioned findings as evidence of selective pressure exerted by the host immune system on Pneumocystis species, shaping the evolution of Msg and several proteins involved in GPI biosynthesis. We suggest that genome evolution in Pneumocystis is well described by the Red-Queen hypothesis whereby genes relevant for biotic interactions show accelerated rates of evolution., L.D. wishes to thank Eugenia Flores and Ana Fayos for support provided. This project has received funding from the Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program under grant agreement No 612583-DEANN. Part of this work was done during an internship of L.D. as invited professor at the Universidad de Valencia. Support from CONACYT (grant 454938) is gratefully acknowledged. This work was supported by grants to A.M. from the Spanish Ministry of Science and Competitivity (projects SAF 2012-31187, SAF2013-49788-EXP, SAF2015-65878-R), Carlos III Institute of Health (projects PIE14/00045, AC 15/00022 and AC15/00042), Generalitat Valenciana (project PrometeoII/2014/065) and cofinanced by FEDER.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Mediterranean diet and white blood cell count — A randomized controlled trial

  • Hernáez, Álvaro
  • Lassale, Camille
  • Castro-Barquero, Sara
  • Babio, Nancy
  • Ros Rahola, Emilio
  • Castañer, Olga
  • Tresserra-Rimbau, Anna
  • Pintó Sala, Xavier
  • Martínez-González, Miguel Ángel
  • Corella Piquer, Dolores
  • Salas Salvadó, Jordi
  • Alonso Gómez, Ángel M.
  • Lapetra, José
  • Fiol, Miquel
  • Gómez-Gracia, Enrique
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • García-Arellano, Ana
  • Sorlí, José V.
  • Díaz López, Andrés
  • Cofán Pujol, Montserrat
  • Estruch Riba, Ramon
We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 109 leukocytes/L), mild leukopenia (<4.5 × 109 leukocytes/L), or severe leukopenia (<3.5 × 109 leukocytes/L) in individuals without the condition at baseline (n = 3190, n = 2925, and n = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HRQ4-Q1: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (P-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator

  • Nonell, Santi
  • Bresolí-Obach, Roger
  • Font Inglès, Joan
  • López-Cano, Marc
  • Notartomaso, Serena
  • Scarselli, Pamela
  • Di Pietro, Paola
  • Battaglia, Giuseppe
  • Malhaire, Fanny
  • Rovira, Xavier
  • Catena, Juanlo
  • Giraldo, Jesús
  • Pin, Jean-Philippe
  • Fernández-Dueñas, Víctor
  • Goudet, Cyril
  • Nicoletti, Ferdinando
  • Llebaria, Amadeu
  • Ciruela, Francisco
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug’s release, which effectively controls mGlu5 receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu5 receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Mediterranean diet decreases the initiation of use of vitamin K epoxide reductase inhibitors and their associated cardiovascular risk: a randomized controlled trial

  • Castro-Barquero, Sara
  • Ribó-Coll, Margarita
  • Lassale, Camille
  • Tresserra-Rimbau, Anna
  • Castañer, Olga
  • Pintó Sala, Xavier
  • Martínez-González, Miguel Ángel, 1957-
  • Sorlí, José V.
  • Salas Salvadó, Jordi
  • Lapetra, José
  • Gómez-Gracia, Enrique
  • Alonso Gómez, Ángel M.
  • Fiol Sala, Miguel
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • Basterra-Gortari, Francisco Javier
  • Portolés, Olga
  • Babio, Nancy
  • Cofán Pujol, Montserrat
  • Ros Rahola, Emilio
  • Estruch Riba, Ramon
  • Hernáez, Álvaro
Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvención con DIeta MEDiterránea (PREDIMED) study allocated to a MedDiet enriched in extra-virgin olive oil or nuts (versus a low-fat control intervention) disclose differences in the risk of initiation of: (1) vitamin K epoxide reductase inhibitors (acenocumarol/warfarin; n = 6772); (2) acetylsalicylic acid as antiplatelet agent (n = 5662); and (3) other antiplatelet drugs (cilostazol/clopidogrel/dipyridamole/ditazol/ticlopidine/triflusal; n = 6768). We also assess whether MedDiet modifies the association between the antithrombotic drug baseline use and incident cardiovascular events. The MedDiet intervention enriched with extra-virgin olive oil decreased the risk of initiating the use of vitamin K epoxide reductase inhibitors relative to control diet (HR: 0.68 [0.46–0.998]). Their use was also more strongly associated with an increased risk of cardiovascular disease in participants not allocated to MedDiet interventions (HRcontrol diet: 4.22 [1.92–9.30], HRMedDiets: 1.71 [0.83–3.52], p-interaction = 0.052). In conclusion, in an older population at high cardiovascular risk, following a MedDiet decreases the initiation of antithrombotic therapies and the risk of suffering major cardiovascular events among users of vitamin K epoxide reductase inhibitors.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Mediterranean diet maintained platelet count within a healthy range and decreased thrombocytopenia-related mortality risk: a randomized controlled trial

  • Hernáez, Álvaro
  • Lassale, Camille
  • Castro-Barquero, Sara
  • Ros Rahola, Emilio
  • Tresserra-Rimbau, Anna
  • Castañer, Olga
  • Pintó Sala, Xavier
  • Vázquez Ruiz, Zenaida
  • Sorlí, José V.
  • Salas Salvadó, Jordi
  • Lapetra, José
  • Gómez-Gracia, Enrique
  • Alonso Gómez, Ángel M.
  • Fiol, Miquel
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • Razquin, Cristina
  • Corella Piquer, Dolores
  • Guasch-Ferré, Marta
  • Cofán Pujol, Montserrat
  • Estruch Riba, Ramon
There is little information on the dietary modulation of thrombosis-related risk factors such as platelet count. We aimed to assess the effects of Mediterranean diet (MedDiet) on platelet count and related outcomes in an older population at high cardiovascular risk. In participants of the PREDIMED (PREvención con DIeta MEDiterránea) study, we assessed whether an intervention with a MedDiet enriched with extra-virgin olive oil or nuts, relative to a low-fat control diet, modulated platelet count (n = 4189), the risk of developing thrombocytosis and thrombocytopenia (n = 3086), and the association between these alterations and all-cause mortality (median follow-up time: 3.0 years). Although platelet count increased over time (+0.98·109 units/L·year [95% confidence interval: 0.12; 1.84]), MedDiet interventions moderated this increase, particularly in individuals with near-high baseline count (both MedDiets combined: −3.20·109 units/L·year [−5.81; −0.59]). Thrombocytopenia incidence was lower in the MedDiet interventions (incidence rates: 2.23% in control diet, 0.91% in MedDiets combined; hazard ratio: 0.44 [0.23; 0.83]). Finally, thrombocytopenia was associated with a higher risk of all-cause mortality (hazard ratio: 4.71 [2.69; 8.24]), but this relationship was attenuated in those allocated to MedDiet (p-interaction = 0.018). In brief, MedDiet maintained platelet counts within a healthy range and attenuated platelet-related mortality in older adults at high cardiovascular risk.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals

  • Guzmán Ruiz, R.
  • Tercero-Alcázar, C.
  • Rabanal Ruiz, Yoana
  • Díaz-Ruiz, Alberto
  • Bekay, Rajaa El
  • Rangel-Zuñiga, Oriol Alberto
  • Navarro-Ruiz, Carmen
  • Molero, Laura
  • Membrives, Antonio
  • Ruiz-Rabelo, Juan F.
  • Pandit, A.
  • López-Miranda, José
  • Tinahones, Francisco J.
  • Malagón, María M.
Adipose tissue dysregulation in obesity strongly influences systemic metabolic homeostasis and is often linked to insulin resistance (IR). However, the molecular mechanisms underlying adipose tissue dysfunction in obesity are not fully understood. Herein, a proteomic analysis of subcutaneous (SC) and omental (OM) fat from lean subjects and obese individuals with different degrees of insulin sensitivity was performed to identify adipose tissue biomarkers related to obesity-associated metabolic disease. Our results suggest that dysregulation of both adipose tissue extracellular matrix (ECM) organization and intracellular trafficking processes may be associated with IR in obesity. Thus, abnormal accumulation of the small leucine-rich proteoglycan, lumican, as observed in SC fat of IR obese individuals, modifies collagen I organization, impairs adipogenesis and activates stress processes [endoplasmic reticulum and oxidative stress] in adipocytes. In OM fat, IR is associated with increased levels of the negative regulator of the Rab family of small GTPases, GDI2, which alters lipid storage in adipocytes by inhibiting insulin-stimulated binding of the Rab protein, Rab18, to lipid droplets. Together, these results indicate that lumican and GDI2 might play depot-dependent, pathogenic roles in obesity-associated IR. Our findings provide novel insights into the differential maladaptive responses of SC and OM adipose tissue linking obesity to IR.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study

  • Gómez Delgado, Francisco
  • Alcalá Díaz, Juan Francisco
  • León-Acuña, Ana
  • López-Moreno, Javier
  • Delgado-Lista, Javier
  • Gómez Marín, Beatriz
  • Roncero-Ramos, Irene
  • Yubero-Serrano, Elena M.
  • Rangel-Zuñiga, Oriol Alberto
  • Vals-Delgado, Cristina
  • Luque, Raúl M.
  • Ordovás, José María
  • López-Miranda, José
  • Pérez-Martínez, Pablo
Background: We try to explore whether long-term consumption of two healthy dietary patterns (low-fat [LF] diet or Mediterranean diet [MedDiet]) interacts with the apolipoprotein E (APOE) single-nucleotide polymorphisms (SNPs: rs439401, rs440446 and rs7412) modulating postprandial hypertriglyceridemia (ppHTG) in coronary heart disease (CHD) patients. Methods and results: We selected patients from the CORDIOPREV study with genotyping and who underwent an oral fat load test (FLT) at baseline and after 3 years follow-up (n = 506). After 3 years of follow-up, we found a gene-diet interaction between the APOE rs439401 SNP and MedDiet. Specifically, T-allele carriers in the MedDiet group showed a more significant decrease in postprandial triglycerides (TG: P = 0.03) and large triacylglycerol-rich lipoproteins (TRLs) TG (large TRLs TG; P = 0.01) compared with CC subjects. Consistently, the area under the curve of TG (AUC-TG; P-interaction = 0.03) and AUC-large TRLs TG (P-interaction = 0.02) were significantly lower in T-allele carriers compared with CC subjects. Conclusions: The long-term consumption of a MedDiet modulates ppHTG through APOE genetic variants in CHD patients. This gene-diet interaction may contribute to a more precise dietary advice in CHD patients.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial

  • Quintana-Navarro, Gracia M.
  • Alcalá Díaz, Juan Francisco
  • López-Moreno, Javier
  • Pérez‑Corral, Isabel
  • León-Acuña, Ana
  • Torres‑Peña, J.D.
  • Rangel Zúñiga, Oriol Alberto
  • Arenas de Larriva, Antonio P.
  • Corina Baba, Andreea
  • Camargo García, A.
  • Yubero-Serrano, Elena M.
  • Rodríguez-Cantalejo, Fernando
  • García-Ríos, Antonio
  • Luque, R.M.
  • Ordovás, José María
  • Pérez-Martínez, Pablo
  • López-Miranda, José
  • Delgado-Lista, Javier
Purpose: Adherence to a healthy dietary pattern positively influences clinical outcomes in cardiovascular prevention, but long-term adherence is difficult to maintain. We evaluated 5-year changes in dietary habits, adherence achieved, and its maintenance in a cohort of coronary patients from the CORDIOPREV study. Methods: 1002 coronary patients were randomized to a Mediterranean diet (n = 502) or a low-fat diet (n = 500) and received individual-group-telephone visits and personalized dietary advice. A validated food-frequency questionnaire, a 14-point Mediterranean diet adherence screener, and a 9-point low-fat diet adherence score were used. Dietary adherence was categorized into Low, Medium, and High Adherence. Changes in nutrient intake, food consumption, and adherence were analyzed on a yearly basis. The maintenance of long-term dietary adherence was evaluated using data after the first year and fifth year. Results: From baseline to 5 years, significant increases were observed in overall dietary adherence (Mediterranean diet from 8.9 to 11.4; low-fat diet from 3.9 to 7.1) and in the percentage of patients considered High Adherence (Mediterranean diet from 41 to 89%; low-fat diet from 4 to 67%). When we evaluated the maintenance of adherence, patients considered Low and Medium Adherence at 1 year increased their adherence at the 5 years with both diets and patients considered High Adherence maintained their adherence with a Mediterranean diet, but decreased their adherence with a low-fat diet. Conclusions: A comprehensive dietary intervention results in an overall long-term improvement and maintenance of adherence to the Mediterranean and low-fat diets. In our population, the Mediterranean diet group achieved a high level of adherence in the short term which was maintained in the long term.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer’s Disease

  • Marrugo-Ramírez, José
  • Rodríguez-Núñez, Montserrat
  • Marco, María Pilar
  • Mir, Mònica
  • Samitier, Josep
Alzheimer’s disease (AD) is a neurodegenerative disorder, characterized by a functional deterioration of the brain. Currently, there are selected biomarkers for its diagnosis in cerebrospinal fluid. However, its extraction has several disadvantages for the patient. Therefore, there is an urgent need for a detection method using sensitive and selective blood-based biomarkers. Kynurenic acid (KYNA) is a potential biomarker candidate for this purpose. The alteration of the KYNA levels in blood has been related with inflammatory processes in the brain, produced as a protective function when neurons are damaged. This paper describes a novel electrochemical immunosensor for KYNA detection, based on successive functionalization multi-electrode array. The resultant sensor was characterized by cyclic voltammetry (CV), chronoamperometry (CA), and electrochemical impedance spectroscopy (EIS). The proposed biosensor detects KYNA within a linear calibration range from 10 pM to 100 nM using CA and EIS, obtaining a limit of detection (LOD) of 16.9 pM and 37.6 pM in buffer, respectively, being the lowest reported LOD for this biomarker. Moreover, to assess our device closer to the real application, the developed immunosensor was also tested under human serum matrix, obtaining an LOD of 391.71 pM for CA and 278.8 pM for EIS with diluted serum., The Nanobioengineering group has support from the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (2017 SGR 1079) and is part of the CERCA Programme/Generalitat de Catalunya. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund (CB06/01/0055). The work developed by the Nanobiotechnology for Diagnostics (Nb4D) group has been funded by the Ministry of Science and Innovation (TryKySeNS project, CTQ2011-29163-C03-01), and the Ministry of Economy and Competitiveness (Molecular links between diabetes and neurodegenerative disorders, Integrated Projects of Excellence in CIBER, PIE14/00061). The Nb4D group is a consolidated research group (Grup de Recerca) of the Generalitat de Catalunya and has support from the Departament d’Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya (expedient: 2017 SGR 1441)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Insulin-like Growth Factor I Couples Metabolism with Circadian Activity through Hypo-Thalamic Orexin Neurons

  • Pignatelli Garrigos, Jaime
  • Fernandez de Sevilla, M.E.
  • Sperber, Jacob
  • Horrillo, Daniel
  • Medina-Gómez, Gema
  • Torres Alemán, Ignacio
Uncoupling of metabolism and circadian activity is associated with an increased risk of a wide spectrum of pathologies. Recently, insulin and the closely related insulin-like growth factor I (IGF-I) were shown to entrain feeding patterns with circadian rhythms. Both hormones act centrally to modulate peripheral glucose metabolism; however, whereas central targets of insulin actions are intensely scrutinized, those mediating the actions of IGF-I remain less defined. We recently showed that IGF-I targets orexin neurons in the lateral hypothalamus, and now we evaluated whether IGF-I modulates orexin neurons to align circadian rhythms with metabolism. Mice with disrupted IGF-IR activity in orexin neurons (Firoc mice) showed sexually dimorphic alterations in daily glucose rhythms and feeding activity patterns which preceded the appearance of metabolic disturbances. Thus, Firoc males developed hyperglycemia and glucose intolerance, while females developed obesity. Since IGF-I directly modulates orexin levels and hepatic expression of KLF genes involved in circadian and metabolic entrainment in an orexin-dependent manner, it seems that IGF-I entrains metabolism and circadian rhythms by modulating the activity of orexin neurons., This research was funded by a grant from Ciberned (Instituto de Salud Carlos III, Spain), an Inter-CIBER project (PIE14/00061), part of the projects PID2019-104376RB-I00 funded by MCIN/AEI/10.13039/ 501100011033; and a grant by Comunidad de Madrid through the European Social Fund (ESF)-financed program NEUROMETAB-CM (B2017/BMD-3700) to ITA. Sperber, Jacob was funded by a Fulbright grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Insulin regulates neurovascular coupling through astrocytes

  • Fernández, Ana M.
  • Martinez-Rachadell, Laura
  • Navarrete, Marta
  • Pose-Utrilla, Julia
  • Dávila, José C.
  • Pignatelli Garrigos, Jaime
  • Diaz-Pacheco, Sonia
  • Guerra-Cantera, Santiago
  • Viedma-Moreno, Emilia
  • Ruiz de Martin Esteban, Samuel
  • Mostany, Ricardo
  • García-Cáceres, Cristina
  • Tschöp, Matthias
  • Iglesias, Teresa
  • Ceballos, María L. de
  • Gutiérrez, A.
  • Torres Alemán, Ignacio
Mice with insulin receptor (IR)-deficient astrocytes (GFAP-IR knockout [KO] mice) show blunted responses to insulin and reduced brain glucose uptake, whereas IRdeficient astrocytes show disturbed mitochondrial responses to glucose. While exploring the functional impact of disturbed mitochondrial function in astrocytes, we observed that GFAP-IR KO mice show uncoupling of brain blood flow with glucose uptake. Since IR-deficient astrocytes show higher levels of reactive oxidant species (ROS), this leads to stimulation of hypoxia-inducible factor-1¿ and, consequently, of the vascular endothelial growth factor angiogenic pathway. Indeed, GFAP-IR KO mice show disturbed brain vascularity and blood flow that is normalized by treatment with the antioxidant N-acetylcysteine (NAC). NAC ameliorated high ROS levels, normalized angiogenic signaling and mitochondrial function in IR-deficient astrocytes, and normalized neurovascular coupling in GFAP-IR KO mice. Our results indicate that by modulating glucose uptake and angiogenesis, insulin receptors in astrocytes participate in neurovascular coupling., We are thankful to M.Garcia and R. Cañadas for technical support. This work was funded by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) (Instituto de Salud CarlosIII, Spain) to I.T.A., A.G., and T.I.; an Inter-CIBER project (PIE14/00061) to I.T.A.that forms part of the projects PID2019-104376RB-I00 (I.T.A.) and RTI2018-094887-B-I00 (M.N.) funded by MCIN/AEI/10.13039/501100011033; a grant from Junta de Andalucia Consejería de Economía y Conocimiento (P18-RT-2233 to A.G.) cofinanced by Programa Operativo FEDER 2014–2020; a grant from Instituto de Salud Carlos III Spain (cofinanced by FEDER funds from the European Union; PI21/00915 to A.G.); Grant PID2020-115218RB-I00 to T.I. funded by Ministerio de Ciencia e Innovación/Agencia Española de Investigación (MCIN/AEI/10.13039/501100011033); and a grant from Comunidad de Madrid through the European Social Fund (ESF)–financed programme Neurometabolismo-Comunidad de Madrid (NEUROMETAB-CM) (B2017/BMD-3700 to I.T.A.and T.I.). M.N. was also supported by the Spanish Ministry of Science and Innovation (Ramón y Cajal RYC-2016-20414). J.P.-U. was contracted by CIBERNED.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mediterranean diet and white blood cell count — A randomized controlled trial

  • Hernáez, Álvaro
  • Lassale, Camille
  • Castro-Barquero, Sara
  • Babio, Nancy
  • Ros Rahola, Emilio
  • Castañer, Olga
  • Tresserra-Rimbau, Anna
  • Pintó Sala, Xavier
  • Martínez-González, Miguel Ángel
  • Corella Piquer, Dolores
  • Salas Salvadó, Jordi
  • Alonso Gómez, Ángel M.
  • Lapetra, José
  • Fiol, Miquel
  • Gómez-Gracia, Enrique
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • García-Arellano, Ana
  • Sorlí, José V.
  • Díaz López, Andrés
  • Cofán Pujol, Montserrat
  • Estruch Riba, Ramon
We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 109 leukocytes/L), mild leukopenia (<4.5 × 109 leukocytes/L), or severe leukopenia (<3.5 × 109 leukocytes/L) in individuals without the condition at baseline (n = 3190, n = 2925, and n = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HRQ4-Q1: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (P-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator

  • Nonell, Santi
  • Bresolí-Obach, Roger
  • Font Inglès, Joan
  • López-Cano, Marc
  • Notartomaso, Serena
  • Scarselli, Pamela
  • Di Pietro, Paola
  • Battaglia, Giuseppe
  • Malhaire, Fanny
  • Rovira, Xavier
  • Catena, Juanlo
  • Giraldo, Jesús
  • Pin, Jean-Philippe
  • Fernández-Dueñas, Víctor
  • Goudet, Cyril
  • Nicoletti, Ferdinando
  • Llebaria, Amadeu
  • Ciruela, Francisco
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug’s release, which effectively controls mGlu5 receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu5 receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mediterranean diet maintained platelet count within a healthy range and decreased thrombocytopenia-related mortality risk: a randomized controlled trial

  • Hernáez, Álvaro
  • Lassale, Camille
  • Castro-Barquero, Sara
  • Ros Rahola, Emilio
  • Tresserra-Rimbau, Anna
  • Castañer, Olga
  • Pintó Sala, Xavier
  • Vázquez Ruiz, Zenaida
  • Sorlí, José V.
  • Salas Salvadó, Jordi
  • Lapetra, José
  • Gómez-Gracia, Enrique
  • Alonso Gómez, Ángel M.
  • Fiol, Miquel
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • Razquin, Cristina
  • Corella Piquer, Dolores
  • Guasch-Ferré, Marta
  • Cofán Pujol, Montserrat
  • Estruch Riba, Ramon
There is little information on the dietary modulation of thrombosis-related risk factors such as platelet count. We aimed to assess the effects of Mediterranean diet (MedDiet) on platelet count and related outcomes in an older population at high cardiovascular risk. In participants of the PREDIMED (PREvención con DIeta MEDiterránea) study, we assessed whether an intervention with a MedDiet enriched with extra-virgin olive oil or nuts, relative to a low-fat control diet, modulated platelet count (n = 4189), the risk of developing thrombocytosis and thrombocytopenia (n = 3086), and the association between these alterations and all-cause mortality (median follow-up time: 3.0 years). Although platelet count increased over time (+0.98·109 units/L·year [95% confidence interval: 0.12; 1.84]), MedDiet interventions moderated this increase, particularly in individuals with near-high baseline count (both MedDiets combined: −3.20·109 units/L·year [−5.81; −0.59]). Thrombocytopenia incidence was lower in the MedDiet interventions (incidence rates: 2.23% in control diet, 0.91% in MedDiets combined; hazard ratio: 0.44 [0.23; 0.83]). Finally, thrombocytopenia was associated with a higher risk of all-cause mortality (hazard ratio: 4.71 [2.69; 8.24]), but this relationship was attenuated in those allocated to MedDiet (p-interaction = 0.018). In brief, MedDiet maintained platelet counts within a healthy range and attenuated platelet-related mortality in older adults at high cardiovascular risk.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mediterranean diet decreases the initiation of use of vitamin K epoxide reductase inhibitors and their associated cardiovascular risk: a randomized controlled trial

  • Castro-Barquero, Sara
  • Ribó-Coll, Margarita
  • Lassale, Camille
  • Tresserra-Rimbau, Anna
  • Castañer, Olga
  • Pintó Sala, Xavier
  • Martínez-González, Miguel Ángel, 1957-
  • Sorlí, José V.
  • Salas Salvadó, Jordi
  • Lapetra, José
  • Gómez-Gracia, Enrique
  • Alonso Gómez, Ángel M.
  • Fiol Sala, Miguel
  • Serra Majem, Lluís
  • Sacanella Meseguer, Emilio
  • Basterra-Gortari, Francisco Javier
  • Portolés, Olga
  • Babio, Nancy
  • Cofán Pujol, Montserrat
  • Ros Rahola, Emilio
  • Estruch Riba, Ramon
  • Hernáez, Álvaro
Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvención con DIeta MEDiterránea (PREDIMED) study allocated to a MedDiet enriched in extra-virgin olive oil or nuts (versus a low-fat control intervention) disclose differences in the risk of initiation of: (1) vitamin K epoxide reductase inhibitors (acenocumarol/warfarin; n = 6772); (2) acetylsalicylic acid as antiplatelet agent (n = 5662); and (3) other antiplatelet drugs (cilostazol/clopidogrel/dipyridamole/ditazol/ticlopidine/triflusal; n = 6768). We also assess whether MedDiet modifies the association between the antithrombotic drug baseline use and incident cardiovascular events. The MedDiet intervention enriched with extra-virgin olive oil decreased the risk of initiating the use of vitamin K epoxide reductase inhibitors relative to control diet (HR: 0.68 [0.46–0.998]). Their use was also more strongly associated with an increased risk of cardiovascular disease in participants not allocated to MedDiet interventions (HRcontrol diet: 4.22 [1.92–9.30], HRMedDiets: 1.71 [0.83–3.52], p-interaction = 0.052). In conclusion, in an older population at high cardiovascular risk, following a MedDiet decreases the initiation of antithrombotic therapies and the risk of suffering major cardiovascular events among users of vitamin K epoxide reductase inhibitors.
Docta Complutense
Publication Artículo científico (JournalArticle)

Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis

  • González-Rodríguez, Águeda
  • Valdecantos, M. Pilar
  • Rada, Patricia
  • Addante, Annalisa
  • Barahona, Inés
  • Rey, Esther
  • Pardo, Virginia
  • Ruiz, Laura
  • Laiglesia, Laura M.
  • Moreno-Aliaga, María J.
  • García-Monzón, Carmelo
  • Sánchez Muñoz, Aranzazu
  • Martínez Valverde, Ángela María
Objectives: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries. Protein tyrosine phosphatase 1B (PTP1B), a negative modulator of insulin and cytokine signaling, is a therapeutic target for type 2 diabetes and obesity. We investigated the impact of PTP1B deficiency during NAFLD, particularly in non-alcoholic steatohepatitis (NASH). Methods: NASH features were evaluated in livers from wild-type (PTP1BWT) and PTP1B-deficient (PTP1BKO) mice fed methionine/cholinedeficient diet (MCD) for 8 weeks. A recovery model was established by replacing MCD to chow diet (CHD) for 2e7 days. Non-parenchymal liver cells (NPCs) were analyzed by flow cytometry. Oval cells markers were measured in human and mouse livers with NASH, and in oval cells from PTP1BWT and PTP1BKO mice. Results: PTP1BWT mice fed MCD for 8 weeks exhibited NASH, NPCs infiltration, and elevated Fgf21, Il6 and Il1b mRNAs. These parameters decreased after switching to CHD. PTP1B deficiency accelerated MCD-induced NASH. Conversely, after switching to CHD, PTP1BKO mice rapidly reverted NASH compared to PTP1BWT mice in parallel to the normalization of serum triglycerides (TG) levels. Among NPCs, a drop in cytotoxic natural killer T (NKT) subpopulation was detected in PTP1BKO livers during recovery, and in these conditions M2 macrophage markers were upregulated. Oval cells markers (EpCAM and cytokeratin 19) significantly increased during NASH only in PTP1B-deficient livers. HGF-mediated signaling and proliferative capacity were enhanced in PTP1BKO oval cells. In NASH patients, oval cells markers were also elevated. Conclusions: PTP1B elicits a dual role in NASH progression and reversion. Additionally, our results support a new role for PTP1B in oval cell proliferation during NAFLD.
Docta Complutense
Publication Artículo científico (JournalArticle)

Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity

  • Raposo López-Pastor, Andrea
  • Gómez Hernández, María De La Almudena
  • Díaz Castroverde, Sabela
  • González-Aseguinolaza Gloria
  • González Rodríguez, Águeda
  • García, Gema
  • Fernández, Silvia
  • Escribano Illanes, Óscar
  • Benito, Manuel
Among the main complications associated to obesity is insulin resistance and an altered glucose and lipid metabolism within the liver. It has been previously described that insulin receptor isoform A (IRA) favors glucose uptake and glycogen storage in hepatocytes as compared to isoform B (IRB) improving glucose homeostasis in mice lacking liver insulin receptor. Thus, we hypothesized that IRA could also improve glucose and lipid metabolism in a mouse model of high fat diet-induced obesity. We addressed the role of insulin receptor isoforms on glucose and lipid metabolism in vivo. We expressed IRA or IRB specifically in the liver by using adeno-associated viruses (AAV) in a mouse model of diet-induced insulin resistance and obesity. IRA expression, but not IRB, induced an increased glucose uptake in the liver and muscle improving insulin tolerance. Regarding lipid metabolism, we found that AAV-mediated IRA expression also ameliorated hepatic steatosis by decreasing the expression of Fasn, Pgc1a, Acaca and Dgat2 and increasing Scd-1. Taking together, our results further unravel the role of insulin receptor isoforms in hepatic glucose and lipid metabolism in an insulin-resistant scenario. Our data strongly suggest that IRA is more efficient than IRB favoring hepatic glucose uptake, improving insulin tolerance and ameliorating hepatic steatosis. Therefore, we conclude that a gene therapy approach for hepatic IRA expression could be a safe and promising tool for the regulation of hepatic glucose consumption and lipid metabolism, two key processes in the development of non-alcoholic fatty liver disease (NAFLD) associated to obesity.
Docta Complutense
Publication Artículo científico (JournalArticle)

Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model

  • Gómez Hernández, María De La Almudena
  • Heras Jiménez, Natalia De Las
  • López-Pastor, Andrea R.
  • García-Gómez, Gema
  • Infante-Menéndez, Jorge
  • González-López, Paula
  • González-Illanes, Tamara
  • Lahera Julia, Vicente
  • Benito De Las Heras, Manuel R.
  • Escribano Illanes, Óscar
Background: Cardiovascular dysfunction is linked to insulin-resistant states. In this paper, we analyzed whether the severe hepatic insulin resistance of an inducible liver-specific insulin receptor knockout (iLIRKO) might generate vascular insulin resistance and dysfunction, and whether insulin receptor (IR) isoforms gene therapy might revert it. Methods: We studied in vivo insulin signaling in aorta artery and heart from iLIRKO. Vascular reactivity and the mRNA levels of genes involved in vascular dysfunction were analyzed in thoracic aorta rings by qRT-PCR. Finally, iLIRKO mice were treated with hepatic-specific gene therapy to analyze vascular dysfunction improvement. Results: Our results suggest that severe hepatic insulin resistance was expanded to cardiovascular tissues. This vascular insulin resistance observed in aorta artery from iLIRKO mice correlated with a reduction in both PI3K/AKT/eNOS and p42/44 MAPK pathways, and it might be implicated in their vascular alterations characterized by endothelial dysfunction, hypercontractility and eNOS/iNOS levels’ imbalance. Finally, regarding long-term hepatic expression of IR isoforms, IRA was more efficient than IRB in the improvement of vascular dysfunction observed in iLIRKO mice. Conclusion: Severe hepatic insulin resistance is sufficient to produce cardiovascular insulin resistance and dysfunction. Long-term hepatic expression of IRA restored the vascular damage observed in iLIRKO mice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Aberrant epigenome in -derived dopaminergic neurons from Parkinson's disease patients

  • Fernández-Santiago, Rubén|||0000-0002-4582-0702
  • Carballo-Carbajal, Iria|||0000-0002-4403-8006
  • Castellano, Giancarlo|||0000-0002-5715-7733
  • Torrent, Roger
  • Richaud, Yvonne
  • Sánchez-Danés, Adriana
  • Vilarrasa-Blasi, Roser
  • Sánchez, Alex|||0000-0002-8673-7737
  • Mosquera, José Luis|||0000-0002-7852-4993
  • Soriano, Jordi
  • López-Barneo, José
  • Canals, Josep M.|||0000-0001-6829-7670
  • Alberch i Vié, Jordi|||0000-0002-8684-2721
  • Raya, Ángel|||0000-0003-2189-9775
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Consiglio, Antonella
  • Martín-Subero, José I.
  • Ezquerra, Mario|||0000-0003-3246-6641
  • Tolosa, Eduardo
The epigenomic landscape of Parkinson's disease () remains unknown. We performed a genomewide methylation and a transcriptome studies in induced pluripotent stem cell ()-derived dopaminergic neurons (n) generated by cell reprogramming of somatic skin cells from patients with monogenic 2-associated (L2) or sporadic (), and healthy subjects. We observed extensive methylation changes in n, and of expression, which were common in L2 and . No significant methylation differences were present in parental skin cells, undifferentiated s nor -derived neural cultures not-enriched-in-n. These findings suggest the presence of molecular defects in somatic cells which manifest only upon differentiation into the n cells targeted in . The methylation profile from n, but not from controls, resembled that of neural cultures not-enriched-in-n indicating a failure to fully acquire the epigenetic identity own to healthy n in . The -associated hypermethylation was prominent in gene regulatory regions such as enhancers and was related to the and/or protein downregulation of a network of transcription factors relevant to (1, 3C1, 4A, and 2). Using a patient-specific -based n model, our study provides the first evidence that epigenetic deregulation is associated with monogenic and sporadic PD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Illuminating phenylazopyridines to photoswitch metabotropic glutamate receptors, from the flask to the animals

  • Gómez-Santacana, Xavier|||0000-0001-8830-0494
  • Pittolo, Silvia|||0000-0002-5673-1692
  • Rovira, Xavier|||0000-0002-9764-9927
  • Lopez, Marc
  • Zussy, Charleine
  • Dalton, James A. R.|||0000-0002-5279-4581
  • Faucherre, Adèle
  • Jopling, Chris
  • Pin, Jean-Philippe|||0000-0002-1423-345X
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Goudet, Cyril|||0000-0002-8255-3535
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Llebaria, Amadeu|||0000-0002-8200-4827
Phenylazopyridines are photoisomerizable compounds with high potential to control biological functions with light. We have obtained a series of phenylazopyridines with light dependent activity as negative allosteric modulators (NAM) of metabotropic glutamate receptor subtype 5 (mGlu). Here we describe the factors needed to achieve an operational molecular photoisomerization and its effective translation into in vitro and in vivo receptor photoswitching, which includes zebrafish larva motility and the regulation of the antinociceptive effects in mice. The combination of light and some specific phenylazopyridine ligands displays atypical pharmacological profiles, including light-dependent receptor overactivation, which can be observed both in vitro and in vivo. Remarkably, the localized administration of light and a photoswitchable compound in the peripheral tissues of rodents or in the brain amygdalae results in an illumination-dependent analgesic effect. The results reveal a robust translation of the phenylazopyridine photoisomerization to a precise photoregulation of biological activity. The cis - trans photoisomerization of phenylazopyridines, allowing mGlu receptor activity photoswitching in cells, is used in vivo to control zebrafish motility with light and analgesia in mice including peripheral and brain localized illumination.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Optical control of pain in vivo with a photoactive mGlu receptor negative allosteric modulator

  • Font Inglès, Joan|||0000-0001-8416-1909
  • López Cano, Marc|||0000-0001-8885-3726
  • Notartomaso, Serena|||0000-0003-4374-9233
  • Scarselli, Pamela|||0000-0002-4245-0849
  • Di Pietro, Paola|||0000-0003-1327-1961
  • Bresolí-Obach, Roger|||0000-0002-7819-7750
  • Battaglia, Giuseppe|||0000-0001-7571-3417
  • Malhaire, Fanny
  • Rovira, Xavier|||0000-0002-9764-9927
  • Catena, Juanlo|||0000-0002-2423-5926
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Pin, Jean-Philippe|||0000-0002-1423-345X
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Goudet, Cyril|||0000-0002-8255-3535
  • Nonell, Santi|||0000-0002-8900-5291
  • Nicoletti, Ferdinando|||0000-0003-0917-443X
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Ciruela, Francisco|||0000-0003-0832-3739
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug's release, which effectively controls mGlu receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons

  • Urrea, Laura
  • Segura-Feliu, Miriam
  • Masuda-Suzukake, Masami
  • Hervera Abad, Arnau|||0000-0001-8362-369X
  • Pedraz, Lucas
  • García Aznar, José Manuel
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Samitier, Josep|||0000-0002-1140-3679
  • Torrents, Eduard|||0000-0002-3010-1609
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Gavín, Rosalina|||0000-0003-1982-2162
  • Hagesawa, Masato
  • Rio, Jose Antonio del|||0000-0002-5214-4909
The cellular prion protein, encoded by the gene Prnp, has been reported to be a receptor of β-amyloid. Their interaction is mandatory for neurotoxic effects of βamyloid oligomers. In this study, we aimed to explore whether the cellular prion protein participates in the spreading of α-synuclein. Results demonstrate that Prnp expression is not mandatory for α-synuclein spreading. However, although the pathological spreading of αsynuclein can take place in the absence of Prnp, αsynuclein expanded faster in PrPC-overexpressing mice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BDNF genetic variants and methylation, effects on cognition in major depressive disorder

  • Ferrer, Alex|||0000-0002-3040-1177
  • Labad, Javier|||0000-0003-2214-1886
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Barrachina, Marta
  • Costas, Javier|||0000-0003-0306-3990
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Crespo, José M.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
Brain-derived neurotrophic factor (BDNF) gene regulation has been linked to the pathophysiology of major depressive disorder (MDD). MDD patients show cognitive deficits, and altered BDNF regulation has a relevant role in neurocognitive functions. Our goal was to explore the association between BDNF genetic and epigenetic variations with neurocognitive performance in a group of MDD patients and healthy controls considering possible modulating factors. The sample included 134 subjects, 64 MDD patients, and 70 healthy controls. Clinical data, childhood maltreatment, and neurocognitive performance were assessed in all participants. Eleven single nucleotide polymorphisms (SNPs) and two promoter regions in the BDNF gene were selected for genotype and methylation analysis. The role of interactions between BDNF genetic and epigenetic variations with MDD diagnosis, sex, and Childhood Trauma Questionnaire (CTQ) scores was also explored. We observed significant associations between neurocognitive performance and two BDNF SNPs (rs908867 and rs925946), an effect that was significantly mediated by methylation values at specific promoter I sites. We identified significant associations between neurocognitive results and methylation status as well as its interactions with MDD diagnosis, sex, and CTQ scores. Our results support the hypothesis that BDNF gene SNPs and methylation status, as well as their interactions with modulating factors, can influence cognition. Further studies are required to confirm the effect of BDNF variations and cognitive function in larger samples.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Control of glutamate release by complexes of adenosine and cannabinoid receptors

  • Köfalvi, Attila
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Cai, Ning-Sheng
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ferreira, Samira G.
  • Guixà González, Ramon|||0000-0003-0397-9800
  • Sánchez Soto, Marta
  • Yano, Hideaki
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Cunha, Rodrigo A.
  • Sebastião, Ana Maria
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Casadó, Vicent|||0000-0002-1764-3825
  • Ferré, Sergi|||0000-0002-1747-1779
It has been hypothesized that heteromers of adenosine A receptors (A2AR) and cannabinoid CB receptors (CB1R) localized in glutamatergic nerve terminals mediate the integration of adenosine and endocannabinoid signaling involved in the modulation of striatal excitatory neurotransmission. Previous studies have demonstrated the existence of A2AR-CB1R heteromers in artificial cell systems. A dependence of A2AR signaling for the Gi protein-mediated CB1R signaling was described as one of its main biochemical characteristics. However, recent studies have questioned the localization of functionally significant A2AR-CB1R heteromers in striatal glutamatergic terminals. Using a peptide-interfering approach combined with biophysical and biochemical techniques in mammalian transfected cells and computational modeling, we could establish a tetrameric quaternary structure of the A2AR-CB1R heterotetramer. This quaternary structure was different to the also tetrameric structure of heteromers of A2AR with adenosine A receptors or dopamine D receptors, with different heteromeric or homomeric interfaces. The specific quaternary structure of the A2A-CB1R, which depended on intermolecular interactions involving the long C-terminus of the A2AR, determined a significant A2AR and Gs protein-mediated constitutive activation of adenylyl cyclase. Using heteromer-interfering peptides in experiments with striatal glutamatergic terminals, we could then demonstrate the presence of functionally significant A2AR-CB1R heteromers with the same biochemical characteristics of those studied in mammalian transfected cells. First, either an A2AR agonist or an A2AR antagonist allosterically counteracted Gi-mediated CB1R agonist-induced inhibition of depolarization-induced glutamate release. Second, co-application of both an A2AR agonist and an antagonist cancelled each other effects. Finally, a CB1R agonist inhibited glutamate release dependent on a constitutive activation of A2AR by a canonical Gs-Gi antagonistic interaction at the adenylyl cyclase level. We demonstrate that the well-established cannabinoid-induced inhibition of striatal glutamate release can mostly be explained by a CB1R-mediated counteraction of the A2AR-mediated constitutive activation of adenylyl cyclase in the A2AR-CB1R heteromer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cross-regional view of functional and taxonomic microbiota composition in obesity and post-obesity treatment shows country specific microbial contribution

  • Medina, D. A.
  • Li, Tianlu|||0000-0001-7152-4870
  • Thomson, P.
  • Artacho, Alejandro
  • Pérez-Brocal, Vicente|||0000-0002-1927-9676
  • Moya, Andrés|||0000-0002-2867-1119
Gut microbiota has been shown to have an important influence on host health. The microbial composition of the human gut microbiota is modulated by diet and other lifestyle habits and it has been reported that microbial diversity is altered in obese people. Obesity is a worldwide health problem that negatively impacts the quality of life. Currently, the widespread treatment for obesity is bariatric surgery. Interestingly, gut microbiota has been shown to be a relevant factor in effective weight loss after bariatric surgery. Since that the human gut microbiota of normal subjects differs between geographic regions, it is possible that rearrangements of the gut microbiota in dysbiosis context are also region-specific. To better understand how gut microbiota contribute to obesity, this study compared the composition of the human gut microbiota of obese and lean people from six different regions and showed that the microbiota compositions in the context of obesity were specific to each studied geographic location. Furthermore, we analyzed the functional patterns using shotgun DNA metagenomic sequencing and compared the results with other obesity-related metagenomic studies, we observed that microbial contribution to functional pathways were country-specific. Nevertheless, our study showed that although microbial composition of obese patients was country-specific, the overall metabolic functions appeared to be the same between countries, indicating that different microbiota components contribute to similar metabolic outcomes to yield functional redundancy. Furthermore, we studied the microbiota functional changes of obese patients after bariatric surgery, by shotgun metagenomics sequencing and observed that changes in functional pathways were specific to the type of obesity treatment. In all, our study provides new insights into the differences and similarities of obese gut microbiota in relation to geographic location and obesity treatments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

  • Rojo-Martínez, G.|||0000-0003-2179-2134
  • Valdés, Sergio|||0000-0001-8623-4331
  • Soriguer, Federico|||0000-0002-1992-5666
  • Vendrell, Joan|||0000-0002-6994-6115
  • Urrutia, Isabel|||0000-0001-5386-8776
  • Perez-Valero, Vidal
  • Ortega, Emilio|||0000-0002-2217-8905
  • Ocón, Pilar|||0000-0001-9257-2687
  • Montanya, Eduard|||0000-0003-2518-9076
  • Menéndez Torre, Edelmiro|||0000-0002-9548-7821
  • Lago-Sampedro, Ana|||0000-0002-3072-9981
  • González- Frutos, Teba|||0000-0002-1002-2102
  • Gomis, Ramon|||0000-0002-7285-1328
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Garcia Serrano, Sara|||0000-0002-9547-9637
  • García-Escobar, Eva|||0000-0002-0134-3473
  • Galán-García, José Luis|||0000-0002-8773-6998
  • Castell, Conxa|||0000-0003-2558-1959
  • Badía-Guillén, Rocío
  • Aguilera-Venegas, Gabriel|||0000-0002-5813-6184
  • Girbés, Juan|||0000-0002-1665-4549
  • Gaztambide, Sonia|||0000-0003-3569-2265
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Delgado, Elias|||0000-0001-6114-9712
  • Chaves, Felilpe Javier|||0000-0001-8009-3689
  • Castaño, Luis|||0000-0003-0437-9401
  • Calle-Pascual, Alfonso L.|||0000-0002-3628-9323
Our aim was to determine the incidence of type 2 diabetes mellitus in a nation-wide population based cohort from Spain (di@bet.es study). The target was the Spanish population. In total 5072 people older than 18 years,were randomly selected from all over Spain). Socio-demographic and clinical data, survey on habits (physical activity and food consumption) and weight, height, waist, hip and blood pressure were recorder. A fasting blood draw and an oral glucose tolerance test were performed. Determinations of serum glucose were made. In the follow-up the same variables were collected and HbA1c was determined. A total of 2408 subjects participated in the follow-up. In total, 154 people developed diabetes (6.4% cumulative incidence in 7.5 years of follow-up). The incidence of diabetes adjusted for the structure of age and sex of the Spanish population was 11.6 cases/1000 person-years (IC95% = 11.1-12.1). The incidence of known diabetes was 3.7 cases/1000 person-years (IC95% = 2.8-4.6). The main risk factors for developing diabetes were the presence of prediabetes in cross-sectional study, age, male sex, obesity, central obesity, increase in weight, and family history of diabetes. This work provides data about population-based incidence rates of diabetes and associated risk factors in a nation-wide cohort of Spanish population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dairy Product Consumption and Metabolic Diseases in the Di@bet.es Study

  • Lago-Sampedro, Ana|||0000-0002-3072-9981
  • García-Escobar, Eva|||0000-0002-0134-3473
  • Rubio-Martín, Elehazara
  • Pascual-Aguirre, Nuria
  • Valdés, Sergio|||0000-0001-8623-4331
  • Soriguer, Federico|||0000-0002-1992-5666
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Calle-Pascual, Alfonso L.|||0000-0002-3628-9323
  • Castell, Conxa|||0000-0003-2558-1959
  • Menéndez Torre, Edelmiro|||0000-0002-9548-7821
  • Delgado, Elias|||0000-0001-6114-9712
  • Bordiú, Elena
  • Castaño, Luis|||0000-0003-0437-9401
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Girbés, Juan|||0000-0002-1665-4549
  • Chaves, Felilpe Javier|||0000-0001-8009-3689
  • Gaztambide, Sonia|||0000-0003-3569-2265
  • Rojo-Martínez, G.|||0000-0003-2179-2134
  • Olveira, Gabriel|||0000-0002-7646-2899
To date it is not clear what the role of dairy products is in metabolic diseases like diabetes, obesity, and hypertension. Therefore, the aim of this study is to test the association between dairy product consumption and those pathologies. A cross-sectional study was conducted with 5081 adults included in the di@bet.es study, from 100 health centers around Spain. Food frequency questionnaires were carried out concerning consumption habits, which included dairy product consumption. Logistic regression models were used for the association analyses between the variables controlling confounding variables. Women had a higher consumption of milk, cheese, or yogurt than men (p < 0.0001), but men consumed more sugar dairy products (p < 0.001). People who live in the North of Spain consume more dairy products than those who live in the East. Dairy product consumption was inversely associated with the presence of hypertension regardless of age, sex, geographical region, and body mass index (BMI) (Odds Ratio (OR) 0.743; p = 0.022). The presence of obesity was inversely associated with dairy consumption regardless of age, sex, and geographical region (OR 0.61; p < 0.001). Milk consumption was not associated with diabetes. Our results show that consuming dairy products is associated with a better metabolic profile in the Spanish population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A-Dopamine D Receptor Heterotetramers and Adenylyl Cyclase

  • Ferré, Sergi|||0000-0002-1747-1779
  • Bonaventura, Jordi
  • Zhu, Wendy
  • Hatcher-Solis, Candice
  • Taura, Jaume
  • Quiroz, César
  • Cai, Ning-Sheng
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Kravitz, Alexxai V.
  • Thompson, Kimberly R.
  • Tomasi, Dardo G.
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Lluís, Carme
  • Dessauer, Carmen W.
  • Volkow, Nora|||0000-0001-6668-0908
  • Casadó, Vicent|||0000-0002-1764-3825
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Logothetis, Diomedes E.
  • Zwilling, Daniel
The central adenosine system and adenosine receptors play a fundamental role in the modulation of dopaminergic neurotransmission. This is mostly achieved by the strategic co-localization of different adenosine and dopamine receptor subtypes in the two populations of striatal efferent neurons, striatonigral and striatopallidal, that give rise to the direct and indirect striatal efferent pathways, respectively. With optogenetic techniques it has been possible to dissect a differential role of the direct and indirect pathways in mediating "Go" responses upon exposure to reward-related stimuli and "NoGo" responses upon exposure to non-rewarded or aversive-related stimuli, respectively, which depends on their different connecting output structures and their differential expression of dopamine and adenosine receptor subtypes. The striatopallidal neuron selectively expresses dopamine D receptors (D2R) and adenosine A receptors (A2AR), and numerous experiments using multiple genetic and pharmacological in vitro, in situ and in vivo approaches, demonstrate they can form A2AR-D2R heteromers. It was initially assumed that different pharmacological interactions between dopamine and adenosine receptor ligands indicated the existence of different subpopulations of A2AR and D2R in the striatopallidal neuron. However, as elaborated in the present essay, most evidence now indicates that all interactions can be explained with a predominant population of striatal A2AR-D2R heteromers forming complexes with adenylyl cyclase subtype 5 (AC5). The A2AR-D2R heteromer has a tetrameric structure, with two homodimers, which allows not only multiple allosteric interactions between different orthosteric ligands, agonists, and antagonists, but also the canonical Gs-Gi antagonistic interaction at the level of AC5. We present a model of the function of the A2AR-D2R heterotetramer-AC5 complex, which acts as an integrative device of adenosine and dopamine signals that determine the excitability and gene expression of the striatopallidal neurons. The model can explain most behavioral effects of A2AR and D2R ligands, including the psychostimulant effects of caffeine. The model is also discussed in the context of different functional striatal compartments, mainly the dorsal and the ventral striatum. The current accumulated knowledge of the biochemical properties of the A2AR-D2R heterotetramer-AC5 complex offers new therapeutic possibilities for Parkinson's disease, schizophrenia, SUD and other neuropsychiatric disorders with dysfunction of dorsal or ventral striatopallidal neurons.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Angiotensin II type 1/adenosine A receptor oligomers, a novel target for tardive dyskinesia

  • Oliveira, Paulo A. de|||0000-0002-0852-4920
  • Dalton, James A. R.|||0000-0002-5279-4581
  • López Cano, Marc|||0000-0001-8885-3726
  • Ricarte, Adrià
  • Morató, Xavier|||0000-0002-3012-2864
  • Matheus, Filipe C.
  • Cunha, Andréia S.
  • Müller, Christa E.
  • Takahashi, Reinaldo N.
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Prediger, Rui D.
  • Ciruela, Francisco|||0000-0003-0832-3739
Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D receptors (DRs). Striatal DR functioning may be finely regulated by either adenosine A receptor (AR) or angiotensin receptor type 1 (ATR) through putative receptor heteromers. Here, we examined whether AR and ATR may oligomerize in the striatum to synergistically modulate dopaminergic transmission. First, by using bioluminescence resonance energy transfer, we demonstrated a physical ATR-AR interaction in cultured cells. Interestingly, by protein-protein docking and molecular dynamics simulations, we described that a stable heterotetrameric interaction may exist between ATR and AR bound to antagonists (i.e. losartan and istradefylline, respectively). Accordingly, we subsequently ascertained the existence of ATR/AR heteromers in the striatum by proximity ligation in situ assay. Finally, we took advantage of a TD animal model, namely the reserpine-induced vacuous chewing movement (VCM), to evaluate a novel multimodal pharmacological TD treatment approach based on targeting the ATR/AR complex. Thus, reserpinized mice were co-treated with sub-effective losartan and istradefylline doses, which prompted a synergistic reduction in VCM. Overall, our results demonstrated the existence of striatal ATR/AR oligomers with potential usefulness for the therapeutic management of TD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

  • Robles, Eloy F.
  • Mena-Varas, Maria
  • Barrio, Laura
  • Merino-Cortes, Sara V.
  • Balogh, Péter
  • Du, Ming-Qing
  • Akasaka, Takashi
  • Parker, Anton
  • Roa, Sergio
  • Panizo, Carlos
  • Martin-Guerrero, Idoia
  • Siebert, Reiner
  • Segura, Victor
  • Agirre, Xabier|||0000-0002-6558-9560
  • Macri-Pellizeri, Laura
  • Aldaz, Beatriz
  • Vilas-Zornoza, Amaia|||0000-0001-6693-0989
  • Zhang, Shaowei
  • Moody, Sarah
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Tousseyn, Thomas
  • Broccardo, Cyril
  • Brousset, Pierre
  • Campos-Sanchez, Elena
  • Cobaleda, Cesar|||0000-0003-3807-9204
  • Sánchez García, Isidro
  • Fernandez-Luna, Jose Luis
  • Garcia-Muñoz, Ricardo
  • Pena, Esther
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Salar Silvestre, Antonio|||0000-0002-4652-4825
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • González, Marcos
  • Terol, Maria Jose|||0000-0002-9467-932X
  • Climent Bataller, Joan|||0000-0002-8927-6614
  • Ferrandez, Antonio
  • Sagaert, Xavier
  • Melnick, Ari M.
  • Prosper, Felipe|||0000-0001-6115-8790
  • Oscier, David G.
  • Carrasco, Yolanda R.
  • Dyer, Martin J. S.
  • Martinez-Climent, Jose A.
NKX2 homeobox family proteins have a role in cancer development. Here we show that NKX2 - 3 is overexpressed in tumour cells from a subset of patients with marginal-zone lymphomas, but not with other B-cell malignancies. While Nkx2-3 -deficient mice exhibit the absence of marginal-zone B cells, transgenic mice with expression of NKX2-3 in B cells show marginal-zone expansion that leads to the development of tumours, faithfully recapitulating the principal clinical and biological features of human marginal-zone lymphomas. NKX2-3 induces B-cell receptor signalling by phosphorylating Lyn/Syk kinases, which in turn activate multiple integrins (LFA-1, VLA-4), adhesion molecules (ICAM-1, MadCAM-1) and the chemokine receptor CXCR4. These molecules enhance migration, polarization and homing of B cells to splenic and extranodal tissues, eventually driving malignant transformation through triggering NF-κB and PI3K-AKT pathways. This study implicates oncogenic NKX2-3 in lymphomagenesis, and provides a valid experimental mouse model for studying the biology and therapy of human marginal-zone B-cell lymphomas. The homeobox NKX2 family of transcriptional factors has been shown to regulate fundamental developmental processes. Here, the authors show that NKX2-3 is a bona fide oncogenic driver in marginal-zone B-cell lymphoma and that it promotes lymphomagenesis by shaping lymphocyte dynamics and promoting BCR signalling.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Lower Locus Coeruleus MRI intensity in patients with late-life major depression

  • Guinea-Izquierdo, Andrés
  • Giménez, Mónica|||0000-0003-2757-0145
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Canal-Noguer, Pol
  • Blasco, Gerard|||0000-0002-5302-0625
  • Gascón, Jordi
  • Reñé, Ramon
  • Rico, Inmaculada
  • Camins, Àngels|||0000-0003-2678-8134
  • Aguilera, Carlos
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
The locus coeruleus (LC) is the major noradrenergic source in the central nervous system. Structural alterations in the LC contribute to the pathophysiology of different neuropsychiatric disorders, which may increase to a variable extent the likelihood of developing neurodegenerative conditions. The characterization of such alterations may therefore help to predict progression to neurodegenerative disorders. Despite the LC cannot be visualized with conventional magnetic resonance imaging (MRI), specific MRI sequences have been developed to infer its structural integrity. We quantified LC signal Contrast Ratios (LCCRs) in late-life major depressive disorder (MDD) (n = 37, 9 with comorbid aMCI), amnestic Mild Cognitive Impairment (aMCI) (n = 21, without comorbid MDD), and healthy controls (HCs) (n = 31), and also assessed the putative modulatory effects of comorbidities and other clinical variables. LCCRs were lower in MDD compared to aMCI and HCs. While no effects of aMCI comorbidity were observed, lower LCCRs were specifically observed in patients taking serotonin/norepinephrine reuptake inhibitors (SNRIs). Our results do not support the hypothesis that lower LCCRs characterize the different clinical groups that may eventually develop a neurodegenerative disorder. Conversely, our results were specifically observed in patients with late-life MDD taking SNRIs. Further research with larger samples is warranted to ascertain whether medication or particular clinical features of patients taking SNRIs are associated with changes in LC neurons.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation

  • Herraiz-Martínez, Adela
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Llach, Anna|||0000-0002-7486-1079
  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Nolla-Colomer, Carme|||0000-0002-7681-3556
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Izquierdo-Castro, Paloma|||0000-0003-1494-5665
  • Benitez, Ivan David|||0000-0002-3558-5948
  • Benítez, Raúl|||0000-0002-8782-9406
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Rodríguez-Font, Enrique|||0000-0001-5895-4219
  • Viñolas, Xavier|||0000-0002-8243-1271
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Cinca, Juan|||0000-0003-4819-4265
  • Madsen, Leif Hove|||0000-0001-5493-3998
Atrial fibrillation (AF) has been associated with intracellular calcium disturbances in human atrial myocytes, but little is known about the potential influence of sex and we here aimed to address this issue. Alterations in calcium regulatory mechanisms were assessed in human atrial myocytes from patients without AF or with long-standing persistent or permanent AF. Patch-clamp measurements revealed that L-type calcium current (I ) density was significantly smaller in males with than without AF (-1.15 ± 0.37 vs. -2.06 ± 0.29 pA/pF) but not in females with AF (-1.88 ± 0.40 vs. -2.21 ± 0.0.30 pA/pF). In contrast, transient inward currents (I ) were more frequent in females with than without AF (1.92 ± 0.36 vs. 1.10 ± 0.19 events/min) but not in males with AF. Moreover, confocal calcium imaging showed that females with AF had more calcium spark sites than those without AF (9.8 ± 1.8 vs. 2.2 ± 1.9 sites/µm 2) and sparks were wider (3.0 ± 0.3 vs. 2.2 ± 0.3 µm) and lasted longer (79 ± 6 vs. 55 ± 8 ms), favouring their fusion into calcium waves that triggers I s and afterdepolarizations. This was linked to higher ryanodine receptor phosphorylation at s2808 in women with AF, and inhibition of adenosine A or beta-adrenergic receptors that modulate s2808 phosphorylation was able to reduce the higher incidence of I in women with AF. Perturbations of the calcium homoeostasis in AF is sex-dependent, concurring with increased spontaneous SR calcium release-induced electrical activity in women but not in men, and with diminished I density in men only. This work was supported by grants from The Spanish Ministry of Science Innovation and Universities [.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects

  • López Cano, Marc|||0000-0001-8885-3726
  • Font Inglès, Joan|||0000-0001-8416-1909
  • Aso, Ester|||0000-0003-1836-1747
  • Sahlholm, Kristoffer|||0000-0001-6536-1972
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Giraldo, Jesús|||0000-0001-7082-4695
  • De Koninck, Yves|||0000-0002-5779-9330
  • Hernando, Jordi|||0000-0002-1126-4138
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
Background and Purpose: Opioid-based drugs are the gold standard medicines for pain relief. However, tolerance and several side effects (i.e. constipation and dependence) may occur upon chronic opioid administration. Photopharmacology is a promising approach to improve the benefit/risk profiles of these drugs. Thus, opioids can be locally activated with high spatiotemporal resolution, potentially minimizing systemic-mediated adverse effects. Here, we aimed at developing a morphine photo-derivative (photocaged morphine), which can be activated upon light irradiation both in vitro and in vivo. Experimental Approach: Light-dependent activity of pc-morphine was assessed in cell-based assays (intracellular calcium accumulation and electrophysiology) and in mice (formalin animal model of pain). In addition, tolerance, constipation and dependence were investigated in vivo using experimental paradigms. Key results: In mice, pc-morphine was able to elicit antinociceptive effects, both using external light-irradiation (hind paw) and spinal cord implanted fibre-optics. In addition, remote morphine photoactivation was devoid of common systemic opioid-related undesired effects, namely, constipation, tolerance to the analgesic effects, rewarding effects and naloxone-induced withdrawal. Conclusion and Implications: Light-dependent opioid-based drugs may allow effective analgesia without the occurrence of tolerance or the associated and severe opioid-related undesired effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Optical control of adenosine A3 receptor function in psoriasis

  • López Cano, Marc|||0000-0001-8885-3726
  • Filgaira, Ingrid|||0000-0002-9886-3925
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Tosh, Dilip K.
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Ciruela, Francisco|||0000-0003-0832-3739
Psoriasis is a chronic and relapsing inflammatory skin disease lacking a cure that affects approximately 2% of the population. Defective keratinocyte proliferation and differentiation, and aberrant immune responses are major factors in its pathogenesis. Available treatments for moderate to severe psoriasis are directed to immune system causing systemic immunosuppression over time, and thus concomitant serious side effects (i.e. infections and cancer) may appear. In recent years, the G protein-coupled A receptor (AR) for adenosine has been suggested as a novel and very promising therapeutic target for psoriasis. Accordingly, selective, and high affinity AR agonists are known to induce robust anti-inflammatory effects in animal models of autoimmune inflammatory diseases. Here, we demonstrated the efficacy of a selective AR agonist, namely MRS5698, in preventing the psoriatic-like phenotype in the IL-23 mouse model of psoriasis. Subsequently, we photocaged this molecule with a coumarin moiety to yield the first photosensitive AR agonist, MRS7344, which in photopharmacological experiments prevented the psoriatic-like phenotype in the IL-23 animal model. Thus, we have demonstrated the feasibility of using a non-invasive, site-specific, light-directed approach to psoriasis treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist

  • Taura, Jaume
  • Nolen, Ernest G.
  • Cabré Segura, Gisela|||0000-0003-3104-3364
  • Hernando, Jordi|||0000-0002-1126-4138
  • Squarcialupi, Lucia
  • López Cano, Marc|||0000-0001-8885-3726
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Ciruela, Francisco|||0000-0003-0832-3739
G protein-coupled adenosine receptors are promising therapeutic targets for a wide range of neuropathological conditions, including Parkinson's disease (PD). However, the ubiquity of adenosine receptors and the ultimate lack of selectivity of certain adenosine-based drugs have frequently diminished their therapeutic use. Photopharmacology is a novel approach that allows the spatiotemporal control of receptor function, thus circumventing some of these limitations. Here, we aimed to develop a light-sensitive caged adenosine A receptor (A R) antagonist to photocontrol movement disorders. We synthesized MRS7145 by blocking with coumarin the 5-amino position of the selective A R antagonist SCH442416, which could be photoreleased upon violet light illumination (405 nm). First, the light-dependent pharmacological profile of MRS7145 was determined in A R-expressing cells. Upon photoactivation, MRS7145 precluded A R ligand binding and agonist-induced cAMP accumulation. Next, the ability of MRS7145 to block A R in a light-dependent manner was assessed in vivo. To this end, A R antagonist-mediated locomotor activity potentiation was evaluated in brain (striatum) fiber-optic implanted mice. Upon irradiation (405 nm) of the dorsal striatum, MRS7145 induced significant hyperlocomotion and counteracted haloperidol-induced catalepsy and pilocarpine-induced tremor. Finally, its efficacy in reversing motor impairment was evaluated in a PD animal model, namely the hemiparkinsonian 6-hydroxydopamine (6-OHDA)-lesioned mouse. Photo-activated MRS7145 was able to potentiate the number of contralateral rotations induced by L-3,4-dihydroxyphenylalanine (L-DOPA). Overall, MRS7145 is a new light-operated A R antagonist with potential utility to manage movement disorders, including PD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adenosine a2a receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Duroux, Romain|||0000-0001-7099-1469
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Montiel, José|||0000-0002-3791-5218
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia seen in clinical practice. While some clinical parameters may predict the transition from paroxysmal to persistent AF, the molecular mechanisms behind the AF perpetuation are poorly understood. Thus, oxidative stress, calcium overload and inflammation, among others, are believed to be involved in AF-induced atrial remodelling. Interestingly, adenosine and its receptors have also been related to AF development and perpetuation. Here, we investigated the expression of adenosine A2A receptor (A2AR) both in right atrium biopsies and peripheral blood mononuclear cells (PBMCs) from non-dilated sinus rhythm (ndSR), dilated sinus rhythm (dSR) and AF patients. In addition, plasma adenosine content and adenosine deaminase (ADA) activity in these subjects were also determined. Our results revealed increased A2AR expression in the right atrium from AF patients, as previously described. Interestingly, increased levels of adenosine content and reduced ADA activity in plasma from AF patients were detected. An increase was observed when A2AR expression was assessed in PBMCs from AF subjects. Importantly, a positive correlation (P=0.001) between A2AR expression in the right atrium and PBMCs was observed. Overall, these results highlight the importance of the A2AR in AF and suggest that the evaluation of this receptor in PBMCs may be potentially be useful in monitoring disease severity and the efficacy of pharmacological treatments in AF patients.
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Triazine-Carbosilane Dendrimersomes Enhance Cellular Uptake and Phototoxic Activity of Rose Bengal in Basal Cell Skin Carcinoma Cells

  • Sztandera, Krzysztof
  • Gorzkiewicz, Michael
  • Batal, Mateusz
  • Arkhipova, Valeria
  • Knauer, Nadezhda
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Apartsin, Evgeny
  • Klajnert-Maculewicz, Barbara
Background: The search for new formulations for photodynamic therapy is intended to improve the outcome of skin cancer treatment using significantly reduced doses of photosensitizer, thereby avoiding side effects. The incorporation of photosensitizers into nanoassemblies is a versatile way to increase the efficiency and specificity of drug delivery into target cells. Herein, we report the loading of rose bengal into vesicle-like constructs of amphiphilic triazine-carbosilane dendrons (dendrimersomes) as well as biophysical and in vitro characterization of this novel nanosystem. Methods: Using established protocol and analytical and spectroscopy techniques we were able to synthesized dendrons with strictly designed properties. Engaging biophysical methods (hydrodynamic diameter and zeta potential measurements, analysis of spectral properties, transmission electron microscopy) we confirmed assembling of our nanosystem. A set of in vitro techniques was used for determination ROS generation, (ABDA and H2DCFDA probes), cell viability (MTT assay) and cellular uptake (flow cytometry and confocal microscopy). Results: Encapsulation of rose bengal inside dendrimersomes enhances cellular uptake, intracellular ROS production and concequently, the phototoxicity of this photosensitizer. Conclusion: Triazine-carbosilane dendrimersomes show high capacity as drug carriers for anticancer photodynamic therapy, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Ministerio de Economía, Comercio y Empresa, Comunidad de Madrid, Junta de Comunidades de Castilla-La Mancha
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Alteration of the HIF-1alfa/VEGF Signalling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers

  • Barrios Gumiel, Óscar|||0000-0002-1862-9793
  • Sánchez Gómez, Belén|||0000-0003-0971-1522
  • Rodríguez Prieto, Tamara|||0000-0002-3764-7217
  • Cano Sierra, Jesús|||0000-0002-6643-7534
  • Bort Bueno, Alicia Carmen|||0000-0003-1490-5823
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Díaz-Laviada Marturet, Inés Cecilia|||0000-0001-9704-4373
Current therapies against prostate cancer (PCa) disease, such as surgery, radiotherapy, or in last term chemical castration by androgen deprivation, have led to significant reduction of the incidence of PCa throughout the world. Worse prognosis found in those patients which exhibit castration resistance, relapsing into the disease with e v e n greater aggressiveness. Hypoxia cancer cell adaption has been observed to be closely connected to fatal prognostic tumor features. Therefore, hypoxia adaptive mechanisms of cancer cells have attracted large interest as a relev a n t biological target for treatment-resistant patients. Dendrimer s have been established as a promising nanotechnological tool owing to their beneficial physicochemical features such as multivalency and monodispersity. Herein, we have completed a thorough study to better understand the effect wit h i n the cel l of the already published ruthenium(II)-N-heterocyclic carbene metallodendrimer (G2Ru) that was able to drastically reduce HIF-1 alpha stabilization and exhibited antiproliferative capabi l i t y against androgen-sensitive (LNCaP) and androgen-resistant prostate cancer cells (LNFLU) in vitro. G2Ru, as well as its cationic imidazol i u m precursor (G2P), displayed scaven g i n g properties against intracellula r and externa l l y stimulated ROS levels, which would presumably hinder the stabilization of HIF-1 alpha by prolyl hydroxylase (PHD) inhibition. Furthermore, these dendrimers have shown considerably beneficial properties against tumor progression capabi l i t y in terms of apoptosis, cell cycle, CSCs expression, and epithelial phenotype promotion. Taken all together, in this study we could demonstrate the extraordinary anticancer properties of NHC-based carbosilane dendrimers against androgen-resistant prostate cancer cells in vitro, Instituto de Salud Carlos III, Comunidad de Madrid, Fundación Tatiana Pérez de Guzmán el Bueno, Universidad de Alcalá, Ministerio de Economía, Industria y Competitividad
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Cationic Carbosilane Dendrimers Prevent Abnormal alfa-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

  • Ortega Lopez, Paula|||0000-0003-0377-5429
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Raya, Ángel
  • Ferrer Lorente, Raquel
  • Lozano de la Cruz, Tania
  • Fernández Carasa, Irene
  • Bryszewska, Maria
  • Milowska, Katarzyna
  • Consiglio, Antonella
Accumulation of misfolded alpha-synuclein (alpha-syn) is a hallmark of Parkinson's disease (PD) thought to play important roles in the pathophysiology of the disease. Dendritic systems, able to modulate the folding of proteins, have emerged as promising new therapeutic strategies for PD treatment. Dendrimers have been shown to be effective at inhibiting alpha-syn aggregation in cell-free systems and in cell lines. Here, we set out to investigate the effects of dendrimers on endogenous alpha-syn accumulation in disease-relevant cell types from PD patients. For this purpose, we chose cationic carbosilane dendrimers of bow-tie topology based on their performance at inhibiting alpha-syn aggregation in vitro. Dopamine neurons were differentiated from induced pluripotent stem cell (iPSC) lines generated from PD patients carrying the LRRK2(G20195) mutation, which reportedly display abnormal accumulation of alpha-syn, and from healthy individuals as controls. Treatment of PD dopamine neurons with non-cytotoxic concentrations of dendrimers was effective at preventing abnormal accumulation and aggregation of alpha-syn. Our results in a genuinely human experimental model of PD highlight the therapeutic potential of dendritic systems and open the way to developing safe and efficient therapies for delaying or even halting PD progression., European Research Council, Polish National Agency for Academic Exchange, Ministerio de Economía y Competitividad, Junta de Comunidades de Castilla-La Mancha, Instituto de Salud Carlos III, Agencia de Gestión de Ayudas Universitarias y de Investigación, Comunidad Autónoma de Madrid, Generalitat de Catalunya